Physician profile
Muhammad Ali Khan
NPI 1346401288
$11,636.78
in general payments reported to CMS, 2019-2025
9 companies · $7,349 in 2025
The $7,349 reported for 2025 was more than what 92% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.29 · 2021: $1,242 · 2022: $988 · 2023: $343 · 2024: $1,698 · 2025: $7,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,317 · Travel and Lodging: $705 · Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,317.00 |
| Travel and Lodging | $705.29 |
| Food and Beverage | $367.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,000.00 | 2025 | Endoflip |
| Boston Scientific Corporation | $2,934.33 | 2021-2025 | Resolution 360 Clip, Spyglass, Exalt Model D |
| Fujifilm Healthcare Americas Corporation | $1,317.00 | 2024-2025 | Fujifilm |
| Mauna Kea Technologies, INC. | $160.05 | 2021-2025 | |
| Olympus Corporation of The Americas | $85.98 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $79.76 | 2024-2025 | |
| Evoendo, INC | $26.71 | 2023 | |
| Emd Serono, INC. | $16.66 | 2024 | |
| Pfizer INC. | $16.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.